Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D00ULT
|
|||
Former ID |
DNC004650
|
|||
Drug Name |
1,1,1-Trifluoro-undecan-2-one
|
|||
Synonyms |
CHEMBL90258; 1,1,1-trifluoroundecan-2-one; 1,1,1-trifluoro-2-undecanone; 1,1,1-Trifluoro-undecan-2-one; BDBM50073985; AKOS012260318; 3-octyl-1,1,1-trifluoro-2-propanone; 3-Octyl-1,1,1-trifluoropropan-2-one
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C11H19F3O
|
|||
Canonical SMILES |
CCCCCCCCCC(=O)C(F)(F)F
|
|||
InChI |
1S/C11H19F3O/c1-2-3-4-5-6-7-8-9-10(15)11(12,13)14/h2-9H2,1H3
|
|||
InChIKey |
ZKJPGCCWKBTIBE-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
BioCyc | Anandamide degradation | |||
KEGG Pathway | Retrograde endocannabinoid signaling | |||
Panther Pathway | Anandamide degradation |
References | Top | |||
---|---|---|---|---|
REF 1 | Discovery of a potent, selective, and efficacious class of reversible alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase effective as a... J Med Chem. 2005 Mar 24;48(6):1849-56. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.